pipette
ESEspañol

Denaturation-sensitive BRET probes enable intracellular thermal shift measurements across diverse protein targets and biomolecular complexes

J. D. Vasta, A. Michaud, M. T. Beck, I. Hwang, A. Schwarzenstein, C. R. Corona, P. Sequeira, C. Happe, M. P. Schwalm, B. Gehrke, K. Nealey, S. Russell, B. Mikulsky, K. K. Dunn-Hoffman, C. Damgaard, M. Zhou, S. Berry, L. Usselmann, C. Forbes, M. Vazquez-Chantada, T. B. Lentz, R. L. Johnson, M. R. Slater, C. Ames, M. M. Szewczyk, D. Barsyte-Lovejoy, W. Zhou, M. Cong, P. L. Meisenheimer, J. Shaw, M. B. Robers

PreprintReal-world use

In the authors' words

Thermal shift assays have revolutionized drug discovery, but can be limited in sensitivity and scalability. Combining the unique attributes of differential scanning fluorimetry (DSF) and cellular thermal shift (CETSA), we report the methodological framework for the bioluminescence resonance energy transfer shift assay (BRETSA). BRETSA utilizes denaturation sensitive BRET probes, in combination with luciferase-tagged target proteins, to track and longitudinally record thermal shift in living cells. Denaturation profiles were successfully measured for over 500 globular proteins, spanning 24 target families in diverse cellular compartments. Among these, target engagement was confirmed for over 200 proteins; including validated drug targets as well as understudied members of the kinase subfamily. Leveraging orthosteric, allosteric, and covalent ligands in potency studies, this method offers improved sensitivity and scalability compared to other thermal shift methods. We extend the utility of BRETSA to interrogate target engagement at biomolecular complexes and query cooperative binding for molecular glues and emerging tricomplex drug modalities.

Main resultThe abstract does not state a limitation.

In plain words AI summary

The authors developed a new method called BRETSA that combines two existing techniques to measure how proteins respond to heat inside living cells. They used special light-emitting probes attached to over 500 different proteins from 24 protein families. The method confirmed drug binding for over 200 proteins, including established drug targets and less-studied kinases. BRETSA showed better sensitivity and scalability than other thermal shift methods when testing different types of drug molecules. The authors also used BRETSA to study drug binding at protein complexes and cooperative binding for newer drug types.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Thursday, November 12. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.10.765695